Edition:
United States

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

8.44EUR
11:35am EDT
Change (% chg)

€-0.22 (-2.54%)
Prev Close
€8.66
Open
€8.76
Day's High
€8.76
Day's Low
€8.43
Volume
52,180
Avg. Vol
43,918
52-wk High
€29.70
52-wk Low
€8.43

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 5 5.02 11.00 0.00 4.15
Year Ending Dec-19 4 7.43 13.00 2.00 27.37
Earnings (per share)
Year Ending Dec-18 4 -2.71 -2.25 -3.19 -2.41
Year Ending Dec-19 4 -3.17 -2.35 -3.54 -1.91
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.45 32.71
P/E High - Last 5 Yrs. -- 279.26 47.27
P/E Low - Last 5 Yrs. -- 98.01 24.80
Beta 1.19 0.61 0.87
Price to Sales (TTM) 40.44 110.80 6.42
Price to Book (MRQ) -- 12.48 3.91
Price to Tangible Book (MRQ) -- 18.85 5.97
Price to Cash Flow (TTM) -- 62.31 23.27
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.69
Dividend Yield - 5 Year Avg 0.00 0.21 1.45
Dividend 5 Year Growth Rate -- 2.62 -5.70
Payout Ratio(TTM) -- 5.94 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 179.03 8.45
Sales (TTM) vs TTM 1 Yr. Ago -- 93.99 6.71
Sales - 5 Yr. Growth Rate -10.13 24.50 7.56
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 283.55 25.51
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 23.64 7.60
Capital Spending - 5 Yr. Growth Rate 102.87 38.63 8.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.20
Current Ratio (MRQ) -- 5.47 2.97
LT Debt to Equity (MRQ) -- 15.10 11.21
Total Debt to Equity (MRQ) -- 18.60 14.02
Interest Coverage (TTM) -- -198.17 35.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.03 54.73
Gross Margin - 5 Yr. Avg. -- 52.71 53.30
EBITD Margin (TTM) -997.40 -- --
EBITD - 5 Yr. Avg -582.11 -176.77 15.89
Operating Margin (TTM) -1,004.43 -608.74 3.72
Operating Margin - 5 Yr. Avg. -595.38 -190.37 11.01
Pre-Tax Margin (TTM) -1,000.10 -605.96 4.04
Pre-Tax Margin - 5 Yr. Avg. -613.76 -192.95 11.19
Net Profit Margin (TTM) -1,000.26 -600.63 0.77
Net Profit Margin - 5 Yr. Avg. -613.37 -190.59 7.53
Effective Tax Rate (TTM) -- 11.58 20.44
Effective Tax Rate - 5 Yr. Avg. -- 19.15 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 33,112 5,333,198 715,149,750
Net Income/Employee (TTM) -331,207 -5,689,194 82,590,366
Receivable Turnover (TTM) -- 4.22 5.01
Inventory Turnover (TTM) -- 2.06 3.61
Asset Turnover (TTM) -- 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 0.77 9.73
Return on Assets - 5 Yr. Avg. -33.74 2.50 10.90
Return on Investment (TTM) -- 1.54 12.72
Return on Investment - 5 Yr. Avg. -38.03 1.99 14.02
Return on Equity (TTM) -- 0.30 14.84
Return on Equity - 5 Yr. Avg. -39.60 -2.37 15.37
  1 Year 3 Year 5 Year
Sales % -18.70 18.42 -10.13
EPS (TTM) % -7.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -6.12 -6.68 66 76
13 Week -44.24 -45.62 15 58
26 Week -47.99 -50.70 26 46
52 Week -63.92 -65.31 21 88
YTD -53.19 -54.38 26 83
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.00%
# of Holders: 24
Total Shares Held: 9,685,142
3 Mo. Net Change: -1,324,015
# New Positions: 1
# Closed Positions: 6
# Increased Positions: 5
# Reduced Positions: 8
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.